DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 26, 2019 PRIMARY DOCUMENT
4 Jun 26, 2019 PRIMARY DOCUMENT
4 Jun 26, 2019 PRIMARY DOCUMENT
4 Jun 26, 2019 PRIMARY DOCUMENT
4 Jun 26, 2019 PRIMARY DOCUMENT
4 Jun 26, 2019 PRIMARY DOCUMENT
8-K Jun 21, 2019 FORM 8-K
8-K Jun 19, 2019 FORM 8-K
8-A12B/A Jun 4, 2019 FORM 8-A12B/A
8-K Jun 4, 2019 FORM 8-K
4 May 31, 2019 PRIMARY DOCUMENT
4 May 28, 2019 PRIMARY DOCUMENT
S-8 May 23, 2019 FORM S-8
8-K May 23, 2019 FORM 8-K
10-Q May 13, 2019 FORM 10-Q
8-K May 13, 2019 FORM 8-K
SC 13G Apr 29, 2019 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
DEFA14A Apr 8, 2019 FORM DEFA14A
DEF 14A Apr 8, 2019 FORM DEF 14A
4 Mar 29, 2019 PRIMARY DOCUMENT
PRE 14A Mar 20, 2019 FORM PRE 14A
8-K Mar 19, 2019 FORM 8-K
10-K Mar 19, 2019 FORM 10-K
8-K Feb 26, 2019 FORM 8-K
SC 13G Feb 1, 2019 SCHEDULE 13G
← Newer Page 15 of 18 · 427 filings Older →